logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
C

Charles Herbaux

Montpellier University
H指数:33
被引数:4,864

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Glofitamab plus gemcitabine and oxaliplatin for relapsed/refractory DLBCL: 3-year follow-up of STARGLO

戈利妥昔单抗联合吉西他滨和奥沙利铂治疗复发/难治性弥漫大B细胞淋巴瘤：STARGLO研究的3年随访

Blood Advances
IF7.1
2026-06-130
OAAI
Jeremy S. Abramson; William Townsend; Christopher P. Fox; Matthew Ku; Mark Hertzberg; Hui-Qiang Huang; Huilai Zhang; Dok Hyun Yoon; Won-Seog Kim; Haifaa Abdulhaq; Charles Herbaux; Jan M. Zaucha; Qing-Yuan Zhang; Hung Chang; Yanyan Liu; Chan Yoon Cheah; Herve Ghesquieres; Estefania Mulvihill; Murali Kesavan; Martine Kallemeijn
BRAF inhibitor plus rituximab in classical hairy cell leukaemia: A retrospective multicentre real-life study

BRAF抑制剂联合利妥昔单抗在经典毛细胞白血病中的应用：一项回顾性多中心真实世界研究

British Journal of Haematology
IF3.8
2026-04-090
PRE
Urbain Tauveron-Jalenques; Luca Inchiappa; Jérôme Paillassa; Elsa Maitre; Lise Willems; Nicolas Stocker; Fatiha Merabet; Anne Lok; Diane Lara; Fontanet Bijou; Charles Herbaux; Inès Ramos; Romain Guièze; Cécile Tomowiak; Xavier Troussard
Brexucabtagene autoleucel for BTKi-naive relapsed/refractory mantle cell lymphoma: primary analysis of ZUMA-2 cohort 3

Brexucabtagene autoleucel 用于 BTKi 初治的复发/难治性套细胞淋巴瘤：ZUMA-2 研究队列 3 的主要分析

Blood
IF23.1
2025-10-310
PRE
Tom van Meerten; Marie José Kersten; Gloria Iacoboni; Georg Hess; Pim Mutsaers; Alejandro Martín García-Sancho; Andre Goy; Eva Giné; Brian T. Hill; Wen-Kai Weng; Patrick M. Reagan; Krish Patel; Ahmed Galal; Charles Herbaux; Robin Sanderson; Edouard Forcade; Max S. Topp; Roch Houot; Dan Zheng; Wangshu Zhang; Justyna Kanska; Rhine R. Shen; Rita Damico Khalid; Ioana Kloos; Martin Dreyling; Michael L. Wang
Outcome of Patients with Mantle Cell Lymphoma after Failure of Anti-CD19 CAR-T Cell Therapy: A Descar-T Study By Lysa Group

抗CD19 CAR-T细胞疗法失败后套细胞淋巴瘤患者的结局：Descar-T研究（Lysa集团）

Blood Advances
IF7.1
2025-10-030
OAAI
Marion Aymard; Morgane Cheminant; Roch Houot; Anne Cuozzo; Elodie Gat; Catherine Thieblemont; Laure Ricard; Louise Roulin; Krimo Bouabdallah; Violaine Safar; Stephanie Guidez; Amandine Fayard; Gabriel Brisou; Loic Ysebaert; Olivier Hermine; Benoît Tessoulin; Charles Herbaux; Steven Le Gouill; Clementine Sarkozy
Clinical benefit of tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma: real-world data from the EarlyMIND study

Brisou, G.; Paillassa, J.; Bernard, S.; Tournilhac, O.; Fornecker, L.M.; Maloisel, F.; Gastaud, L.; Durot, E.; Tempescul, A.; Braun, T.; 等. 塔法西单抗联合来那度胺在复发或难治性弥漫大B细胞淋巴瘤中的临床获益：EarlyMIND研究真实世界数据. Haematologica 2025, 110, 2400–2412. [Google Scholar] [CrossRef]

HAEMATOLOGICA
IF7.9
2025-10-010
OAAI
Brisou, Gabriel; Paillassa, Jerome; Bernard, Sophie; Tournilhac, Olivier; Fornecker, Luc-Matthieu; Maloisel, Frederic; Gastaud, Lauris; Durot, Eric; Tempescul, Adrian; Braun, Thorsten; Ivanov, Vadim; Cherel, Brieuc; Serrier, Caroline; Delage, Jeremy; El Yamani, Abderrazak; Delapierre, Baptiste; Lebras, Laure; Lestang, Elsa; Villesuzanne, Camille; Agape, Philippe; Escure, Guillaume; Fouillet, Ludovic; Nicol, Christophe; Olivier, Gaelle; Levy, Anthony; Le Bris, Anne-Sophie; Cassuto, Ophelie; Jacquemelle, Laura; Haioun, Corinne; Herbaux, Charles
B CAR T-CELL THERAPY IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMAS: A MULTICENTER RETROSPECTIVE STUDY FROM THE LOC NETWORK

B CAR T细胞疗法在原发性中枢神经系统淋巴瘤中的应用：LOC网络的多中心回顾性研究

NEURO-ONCOLOGY
IF13.4
2025-10-010
OA
Bouille, F.; Baron, M.; Houot, R.; Ursu, R.; Boussen, I; Soussain, C.; Waultier-Rascalou, A.; Guffroy, B.; Ahle, G.; Blonski, M.; Morschhauser, F.; Willems, L.; Gastinne, T.; Jerome, P.; Molucon-Chabrot, C.; Schmitt, A.; Schenone, L.; Corvilain, E.; Gyan, E.; Jardin, F.; Morel, V; Barrie, M.; Laribi, K.; Alcantara, M.; Campidelli, A.; Herbaux, C.; Hoang-Xuan, K.; Choquet, S.; Houillier, C.
Synthetic Lethal Combinations of DNA Repair Inhibitors and Genotoxic Agents to Target High-Risk Diffuse Large B Cell Lymphoma

合成致死组合：DNA修复抑制剂与基因毒性剂的联用，靶向高风险弥漫性大B细胞淋巴瘤

Hematological Oncology
IF3.9
2025-08-230
OAAI
Sara Ovejero; Julie Devin; Laura Alibert; Camille Soun; Yea-Lih Lin; Laure Dutrieux; Matthieu Abouladze; Elvira Garcia de Paco; Ouissem Karmous Gadacha; Angelos Constantinou; Guillaume Cartron; Charles Herbaux; Olivier Elemento; Philippe Pasero; Sandrine Roulland; Jérôme Moreaux; Caroline Bret
CD200 immune checkpoint expression is associated with inferior outcome in multiple myeloma patients treated with anti-CD38 monoclonal antibodies

CD200免疫检查点表达与接受抗CD38单克隆抗体治疗的骨髓瘤患者不良预后相关

OncoImmunology
IF6.3
2025-07-200
OA
Djamila Chemlal; Camille Pochard; Valentin Jacquier; Angélique Bruyer; Ludovic Gabellier; Léa Fornero; Clément Vempère; Amélie Machura; Guilhem Requirand; Nicolas Robert; Caroline Bret; Guillaume Cartron; Laure Vincent; Hugues de Boussac; Jérôme Moreaux; Charles Herbaux
Atezolizumab, obinutuzumab and venetoclax for the treatment of patients with relapsed/refractory B non-Hodgkin lymphoma: Final analysis of a phase II trial from the LYSA group

阿特珠单抗、奥比妥珠单抗和维奈托克用于治疗复发/难治性B非霍奇金淋巴瘤患者: LYSA组II期试验的最终分析

BRITISH JOURNAL OF HAEMATOLOGY
IF3.8
2025-04-260
OAAI
Charles Herbaux; Emmanuel Bachy; Reda Bouabdallah; Stéphanie Guidez; Olivier Casasnovas; Pierre Feugier; Gandhi Damaj; Hervé Tilly
Efficacy of tazemetostat in combination with R-CHOP in elderly patients newly diagnosed with diffuse large B cell lymphoma: results of the EpiRCHOP phase II study of the LYSA

塔泽莫斯托stat与R-CHOP联合治疗新诊断弥漫性大B细胞淋巴瘤老年患者的疗效：LYSA的EpiRCHOP II期研究结果

ECLINICALMEDICINE
IF10
2025-04-010
PRE
Sarkozy, Clementine; Molina, Thierry Jo; Dubois, Sydney; Portugues, Cedric; Bohers, Elodie; Ysebaert, Loic; Houot, Roch; Pica, Gian Matteo; Ruminy, Philippe; Herbaux, Charles; Gastinne, Thomas; Thieblemont, Catherine; Haioun, Corinne; Guidez, Stephanie; Bonnet, Christophe; Crochet, Gilles; Veresezan, Liana; Choquet, Sylvain; Bachy, Emmanuel; Jardin, Fabrice; Morschhauser, Franck; Ribrag, Vincent
BCL-2 dependence is a favorable predictive marker of response to therapy for chronic lymphocytic leukemia

BCL-2依赖性是慢性淋巴细胞白血病对疗法反应的一个有利的预测性标志物。

MOLECULAR CANCER
IF33.9
2025-03-030
OA
Chong, Stephen Jun Fei; Lu, Junyan; Valentin, Rebecca; Lehmberg, Timothy Z.; Eu, Jie Qing; Wang, Jing; Zhu, Fen; Kong, Li Ren; Fernandes, Stacey M.; Zhang, Jeremy; Herbaux, Charles; Goh, Boon Cher; Brown, Jennifer R.; Niemann, Carsten U.; Huber, Wolfgang; Zenz, Thorsten
Ironomycin induces mantle cell lymphoma cell death by targeting iron metabolism addiction

Ironomycin通过靶向铁代谢依赖性诱导套细胞淋巴瘤细胞死亡

THERANOSTICS
IF13.3
2025-02-030
OA
Ovejero, Sara; Alibert, Laura; Devin, Julie; Caneque, Tatiana; Jacquier, Valentin; Romero, Andrea; Amar, Salome; Abouladze, Matthieu; Paco, Elvira Garcia de; Gadacha, Ouissem Karmous; Requirand, Guilhem; Robert, Nicolas; Zellagui, Miss Leriem; de Boussac, Hugues; Cartron, Guillaume; Chiche, Johanna; Ricci, Jean-Ehrland; Herbaux, Charles; Rodriguez, Raphael; Moreaux, Jerome; Bret, Caroline
PI3Kδ activation, IL-6 overexpression, and CD37 loss cause resistance to naratuximab emtansine in lymphomas
BLOOD ADVANCES
IF7.1
2024-12-130
OAAI
Arribas, Alberto J.; Napoli, Sara; Gaudio, Eugenio; Herbaux, Charles; Cannas, Eleonora; Tarantelli, Chiara; Bordone-Pittau, Roberta; Cascione, Luciano; Munz, Nicolas; Aresu, Luca; Sgrignani, Jacopo; Rinaldi, Andrea; Kwee, Ivo; Rossi, Davide; Cavalli, Andrea; Zucca, Emanuele; Stussi, Georg; Stathis, Anastasios; Sloss, Callum; Davids, Matthew S.; Bertoni, Francesco
Primary Analysis of ZUMA-2 Cohort 3: Brexucabtagene Autoleucel (Brexu-Cel) in Patients (Pts) with Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL) Who Were Naive to Bruton Tyrosine Kinase Inhibitors (BTKi)

ZUMA-2队列3初步分析：在初治布托替尼酪氨酸激酶抑制剂（BTKi）的复发/难治性套细胞淋巴瘤（R/R MCL）患者中应用Brexucabtagene autoleucel（Brexu-Cel）。

BLOOD
IF23.1
2024-11-051
PRE
van Meerten, Tom; Kersten, M. J.; Lacoboni, Gloria; Hess, Georg; Mutsaers, Pim; Garcia-Sancho, Alejandro Martin; Goy, Andre; Gine, Eva; Hill, Brian T.; Weng, Wen-Kai; Dreyling, Martin; Reagan, Patrick M.; Patel, Krish; Galal, Ahmed; Herbaux, Charles; Sanderson, Robin; Zheng, Dan; Kanska, Justyna; Zhang, Wangshu; Khalid, Rita Damico; Kloos, Loana; Wang, Michael
Six-year follow-up of phase II study exploring chemo-free treatment association with idelalisib and obinutuzumab in symptomatic relapsed/ refractory patients with Waldenström's macroglobulinemia
ANNALS OF HEMATOLOGY
IF2.4
2024-11-050
OAAI
Tomowiak, Cecile; Poulain, Stephanie; Nudel, Morgane; Feugier, Pierre; Herbaux, Charles; Mahe, Beatrice; Morel, Pierre; Aurran, Therese; Tournilhac, Olivier; Lepretre, Stephane; Assaad, Souad; Villemagne, Bruno; Casasnovas, Olivier; Lhermitte, Adeline; Roos-Weil, Damien; Torregrosa-Diaz, Jose; Chevret, Sylvie; Leblond, Veronique
Outcome of Patients with Mantle Cell Lymphoma after Failure of Anti-CD19 CAR T-Cell Therapy: A Descar-T Study By Lysa Group

抗CD19 CAR T细胞疗法失败后滤泡性淋巴瘤患者的结局：Lysa Group的Descar-T研究

BLOOD
IF23.1
2024-11-050
PRE
Aymard, Marion; Cheminant, Morgane; Houot, Roch; Cuozzo, Anne; Gat, Elodie; Thieblemont, Catherine; Ricard, Laure; Roulin, Louise; Bouabdallah, Krimo; Safar, Violaine; Guidez, Stephanie; Fayard, Amandine; Brisou, Gabriel; Ysebaert, Loic; Hermine, Olivier; Tessoulin, Benoit; Herbaux, Charles; Le Gouill, Steven; Sarkozy, Clementine
5-y Follow-up of Combination of Ibrutinib, Obinutuzumab and Venetoclax for Patients with Newly Diagnosed Mantle Cell Lymphoma, the Oasis Trial

5年随访：Ibrutinib、Obinutuzumab和Venetoclax联合治疗新诊断套细胞淋巴瘤患者的Oasis试验

BLOOD
IF23.1
2024-11-050
PRE
Tessoulin, Benoit; Morschhauser, Franck; Chiron, David; Bouabdallah, Krimo; Cartron, Guillaume; Rossi, Cedric; Milin, Caroline; Fouillet, Ludovic; Herbaux, Charles; Tchernonog, Emmanuelle; Mcculloch, Rory; Gastinne, Thomas; Callanan, Mary B.; Le Gouill, Steven
Outcome of patients with large B-cell lymphoma treated with tafasitamab plus lenalidomide either before or after CAR T-cell therapy
BLOOD ADVANCES
IF7.1
2024-10-110
OAAI
Camus, Vincent; Houot, Roch; Brisou, Gabriel; Tessoulin, Benoit; Bailly, Sebastien; Sesques, Pierre; Decroocq, Justine; Krzisch, Daphne; Oberic, Lucie; Lemonnier, Francois; Bouabdallah, Krimo; Campidelli, Arnaud; Tounes, Ledraa; Abraham, Julie; Herbaux, Charles; Morschhauser, Franck; Damaj, Gandhi Laurent; Guidez, Stephanie; Carras, Sylvain; Fornecker, Luc-Matthieu; Choquet, Sylvain; Hermine, Olivier; Paillassa, Jerome; Chauchet, Adrien; Casasnovas, Olivier; Rochelle, Laurianne Drieu La; Castilla-Llorente, Cristina; Joris, Magalie; Dupont, Vivien; Le Gouill, Steven; Jardin, Fabrice

研究方向

暂未获取到该数据
R
Roch Houot
H 指数:60论文数:497被引数:1.3万
G
Guillaume Cartron
H 指数:68论文数:632被引数:1.8万
O
Olivier Casasnovas
H 指数:86论文数:635被引数:2.4万
K
Krimo Bouabdallah
H 指数:43论文数:324被引数:7,766
F
Franck Morschhauser
H 指数:92论文数:929被引数:3.3万
S
Stéphanie Guidez
H 指数:20论文数:233被引数:1,764
S
Steven Le Gouill
H 指数:69论文数:705被引数:1.8万
O
Olivier Tournilhac
H 指数:56论文数:453被引数:1.2万
J
Jérôme Moreaux
H 指数:47论文数:386被引数:7,098
C
Caroline Bret
H 指数:17论文数:76被引数:1,497